Cancer
Malignant Gastric Neoplasm
CI-CAN-00001130Explore in graph →
Top-level650 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001130Explore in graph →
Clinical trials
2,844 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (232)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02080650 | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02229058 | Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | completed | Phase 2 | 73 | Sun Yat-sen UniversityOTHER | 1 | Jul 27, 2017 | clinicaltrials |
| Dovitinib Plus Docetaxel in Gastric Cancer |
| completed |
| Phase 1 / Phase 2 |
| 14 |
| Asan Medical CenterOTHER |
| 1 |
| Jul 14, 2017 |
| clinicaltrials |
| NCT02538562 | Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in Korea | completed | — | 1,695 | Hoffmann-La RocheINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00062374 | Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jul 6, 2017 | clinicaltrials |
| NCT01236053 | Cancer in Patients With Gabapentin (GPRD) | completed | — | 2,323,608 | GlaxoSmithKlineINDUSTRY | 0 | Jul 6, 2017 | clinicaltrials |
| NCT01472029 | Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach(HerFLOT) | completed | Phase 2 | 53 | AIO-Studien-gGmbHOTHER | 1 | Jun 19, 2017 | clinicaltrials |
| NCT02801955 | Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma | completed | — | 67 | Bezmialem Vakif UniversityOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT02547064 | Effect of Modified Stylet Angulation on the Intubation With GlideScope®(GlideMStylet) | completed | N/A | 162 | Keimyung University Dongsan Medical CenterOTHER | 0 | Jun 9, 2017 | clinicaltrials |
| NCT01231399 | Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | completed | Phase 1 / Phase 2 | 6 | City of Hope Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00489515 | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | completed | — | 115 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00654160 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT00836992 | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | completed | — | 144 | Mayo ClinicOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT01625702 | Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer | completed | N/A | 138 | Peking UniversityOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03123432 | Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer | completed | N/A | 34 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Apr 21, 2017 | clinicaltrials |
| NCT01657175 | Quality of Life After Oesophageal or Gastric Cancer Surgery | completed | N/A | 82 | Region SkaneOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01444456 | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | completed | — | 1,262 | AmgenINDUSTRY | 9 | Mar 20, 2017 | clinicaltrials |
| NCT01152645 | Study of ARQ 197 Monotherapy(ARQ 197-004) | completed | Phase 2 | 31 | Kyowa Kirin Co., Ltd.INDUSTRY | 2 | Mar 15, 2017 | clinicaltrials |
| NCT00887822 | A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer(AVATAR) | completed | Phase 3 | 202 | Hoffmann-La RocheINDUSTRY | 1 | Mar 1, 2017 | clinicaltrials |
| NCT01099085 | Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients | completed | Phase 3 | 207 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02926716 | NBI for Identifying Resection Margin Status in Gastric Cancer | completed | — | 100 | Ajou University School of MedicineOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02890511 | A Study DHP107, a Novel Oral Paclitaxel Formulation, in Patients With Advanced Solid Tumours or Gastric Cancer | completed | Phase 1 / Phase 2 | 28 | Daehwa Pharmaceutical Co., Ltd.INDUSTRY | 1 | Feb 13, 2017 | clinicaltrials |
| NCT00957424 | Acceptability of Less Harmful Alternatives to Cigarettes | completed | N/A | 67 | Roswell Park Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01401894 | Perception Prognosis, Goals of Treatment, and Communication | completed | — | 50 | Massachusetts General HospitalOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT02458573 | Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic Gastrectomy | completed | Phase 4 | 86 | Yonsei UniversityOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT03024450 | Trastuzumab Based Therapy in HER2 Positive AGC | completed | — | 98 | Shanghai Zhongshan HospitalOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT00477880 | Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer | completed | Phase 1 | 9 | Vanderbilt UniversityOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT01441310 | Laparoscopic Sentinel Node Navigation Surgery for Gastric Cancer(SNNS) | completed | Phase 2 | 101 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01441336 | Laparoscopic Gastrectomy for Advanced Gastric Cancer | completed | Phase 2 | 204 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01938313 | Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy(ERAS) | completed | Phase 2 | 100 | Seoul National University Bundang HospitalOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT00054457 | Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | completed | Phase 2 | 46 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT00022139 | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 56 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00040859 | Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00519324 | Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer | completed | Phase 2 | 54 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT00436241 | A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | completed | Phase 3 | 564 | Hoffmann-La RocheINDUSTRY | 24 | Nov 2, 2016 | clinicaltrials |
| NCT02274376 | Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer | completed | — | 223 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT02560974 | A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer | completed | Phase 3 | 1,035 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | completed | Phase 3 | 316 | Hoffmann-La RocheINDUSTRY | 14 | Nov 2, 2016 | clinicaltrials |
| NCT01216813 | Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer | completed | — | 33 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT02731313 | Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma | completed | — | 420 | Hoffmann-La RocheINDUSTRY | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02903498 | The Maintenance Treatment of UFT in Advanced Gastric Cancer | completed | Phase 2 | 58 | Fudan UniversityOTHER | 0 | Oct 12, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00454636 | A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. | completed | Phase 2 | 158 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Aug 1, 2017source: clinicaltrials